310 related articles for article (PubMed ID: 25272303)
21. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
22. Mesonephric adenocarcinoma of the uterine cervix: A case report and review of the literature.
Tekin L; Yazici A; Akbaba E; Akin MN
J Pak Med Assoc; 2015 Sep; 65(9):1016-7. PubMed ID: 26338754
[TBL] [Abstract][Full Text] [Related]
23. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
Menon S; Kathuria K; Deodhar K; Kerkar R
Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
25. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
Cavalcanti MS; Schultheis AM; Ho C; Wang L; DeLair DF; Weigelt B; Gardner G; Lichtman SM; Hameed M; Park KJ
Int J Gynecol Pathol; 2017 Jan; 36(1):76-89. PubMed ID: 27532149
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas.
Plotzke JM; Zhao R; Hrycaj SM; Harms PW; Mehra R; Chan MP
J Cutan Pathol; 2021 Oct; 48(10):1246-1251. PubMed ID: 33934372
[TBL] [Abstract][Full Text] [Related]
27. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation.
Karafin M; Parwani AV; Netto GJ; Illei PB; Epstein JI; Ladanyi M; Argani P
Am J Surg Pathol; 2011 Sep; 35(9):1264-73. PubMed ID: 21836481
[TBL] [Abstract][Full Text] [Related]
28. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
[TBL] [Abstract][Full Text] [Related]
29. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
30. PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).
Holmes BJ; Gown AM; Vang R; Ronnett BM; Yemelyanova A
Int J Gynecol Pathol; 2014 Jul; 33(4):425-31. PubMed ID: 24901404
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix.
Wong S; Hong W; Hui P; Buza N
Int J Gynecol Pathol; 2017 Mar; 36(2):101-106. PubMed ID: 27362905
[TBL] [Abstract][Full Text] [Related]
32. Mesonephric adenocarcinoma of the vagina with a 3-year follow-up.
Erşahin C; Huang M; Potkul RK; Hammadeh R; Salhadar A
Gynecol Oncol; 2005 Dec; 99(3):757-60. PubMed ID: 16137744
[TBL] [Abstract][Full Text] [Related]
33. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
Xing D; Liang SX; Gao FF; Epstein JI
Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
[TBL] [Abstract][Full Text] [Related]
35. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
36. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
Ferry JA; Scully RE
Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
[TBL] [Abstract][Full Text] [Related]
37. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
38. A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-up.
Bifulco G; Mandato VD; Mignogna C; Giampaolino P; Di Spiezio Sardo A; De Cecio R; De Rosa G; Piccoli R; Radice L; Nappi C
Int J Gynecol Cancer; 2008; 18(5):1127-31. PubMed ID: 18028380
[TBL] [Abstract][Full Text] [Related]
39. Mesonephric adenocarcinoma of cervix: a case report.
Gupta OP; Guirguis MN; Diejomaoh F
Int J Gynaecol Obstet; 1988 Feb; 26(1):137-40. PubMed ID: 2892730
[TBL] [Abstract][Full Text] [Related]
40. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
